123 related articles for article (PubMed ID: 12057621)
1. Clinical and serological studies on CAM-70 live attenuated measles vaccine: an 18-year survey at a pediatric clinic in Japan.
Ozaki T; Matsui Y; Kajita Y; Nishimura N
Vaccine; 2002 Jun; 20(19-20):2618-22. PubMed ID: 12057621
[TBL] [Abstract][Full Text] [Related]
2. Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic.
Ozaki T; Nishimura N; Kajita Y
Vaccine; 2000 May; 18(22):2375-80. PubMed ID: 10738094
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran.
Mirchamsy H; Shafyi A; Rafyi MR; Bahrami S; Nazari P; Fatemie S
J Hyg (Lond); 1974 Apr; 72(2):273-9. PubMed ID: 4522721
[TBL] [Abstract][Full Text] [Related]
4. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
[TBL] [Abstract][Full Text] [Related]
5. [Means of improving measles vaccinal prophylaxis].
Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
[No Abstract] [Full Text] [Related]
6. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
[No Abstract] [Full Text] [Related]
7. Prior DNA vaccination does not interfere with the live-attenuated measles vaccine.
Premenko-Lanier M; Rota P; Rhodes G; Bellini W; McChesney M
Vaccine; 2004 Jan; 22(5-6):762-5. PubMed ID: 14741170
[TBL] [Abstract][Full Text] [Related]
8. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
[TBL] [Abstract][Full Text] [Related]
9. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain].
Zhang SJ; Xiao QY; Li FJ
Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967
[TBL] [Abstract][Full Text] [Related]
10. Clinical and serological evaluation of live measles vaccine in India.
Phadke MA; Rodrigues JJ; Mehta JM; Ayachit V
Indian Pediatr; 1983 Aug; 20(8):573-6. PubMed ID: 6662582
[No Abstract] [Full Text] [Related]
11. Booster vaccination with further live attenuated measles vaccine.
Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous administration of live attenuated measles vaccine with DTP vaccine.
McBean AM; Gateff C; Manclark CR; Foster SO
Pediatrics; 1978 Sep; 62(3):288-93. PubMed ID: 704197
[TBL] [Abstract][Full Text] [Related]
13. A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
Simon JK; Pasetti MF; Viret JF; Mischler R; Muñoz A; Lagos R; Levine MM; Campbell JD
Hum Vaccin; 2007; 3(2):54-8. PubMed ID: 17312403
[TBL] [Abstract][Full Text] [Related]
14. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
Fulginiti VA; Helfer RE
JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
[TBL] [Abstract][Full Text] [Related]
15. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
[TBL] [Abstract][Full Text] [Related]
16. Trial of a reduced dose of measles vaccine in Nigerian children.
Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
[TBL] [Abstract][Full Text] [Related]
17. Measles vaccines used in Japan.
Hirayama M
Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
[TBL] [Abstract][Full Text] [Related]
18. Development of measles vaccines in Japan.
Ueda S
Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures.
Lancet; 1977 Sep; 2(8038):571-5. PubMed ID: 71396
[TBL] [Abstract][Full Text] [Related]
20. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
